fda approvals in hematologic malignancies, sbla accepted in multiple myeloma, and more
Published 7 years ago • 116 plays • Length 10:23
Download video MP4
Download video MP3
Similar videos
-
10:47
fda approvals in myeloma and itp, applications accepted in myeloma and more
-
11:50
fda approval in myeloma, priority review in dlbcl, application accepted of a biosimilar, and more
-
9:57
fda approvals in fl and rcc, breakthrough designation in myeloma, and more
-
1:34
dr. anderson on recent fda approvals in multiple myeloma
-
9:24
fda approvals in myeloma and head and neck cancer, and findings across several tumor types
-
10:49
fda approvals in myeloma, nets, and of a biosimilar, priority review in ovarian cancer, and more
-
9:02
fda approval in sarcoma, priority reviews in mcrpc and myeloma, and more
-
8:29
fda approval in multiple myeloma, priority reviews in dlbcl and myeloma, and more
-
10:55
fda approval in myeloma, label update in her2 breast cancer, and more
-
0:37
j&j’s carvykti and bms’ abecma win fda approvals for earlier use in multiple myeloma
-
10:08
fda approvals in myeloma and attp, priority review designations in rcc and hnscc, and more
-
8:00
fda approval in rcc, european approvals in myeloma and melanoma, and 2016 aua highlights
-
6:50
novel agents in nhl, fda approval in myeloma, combination trials with atezolizumab, and more
-
9:17
fda approvals in cscc, nsclc, and myeloma, breakthrough designation in prostate cancer, and more
-
10:20
fda approvals in myeloma and thyroid cancer, priority review and nda in nsclc, and more
-
9:53
recent fda approvals for multiple myeloma and what to expect from treatments in development
-
7:49
fda approval sought in multiple myeloma, 2017 aacr annual meeting highlights, and more
-
9:45
fda approval of a biosimilar, promising data in myeloma and gbm, and more
-
6:27
fda approval in myeloma, priority review in all, and 2017 gu cancers symposium highlights
Clip.africa.com - Privacy-policy